Coronavirus: 16,000 Hong Kong patients receive new oral anti-Covid drugs with favourable outcomes, few side effects reported, authorities say | South China Morning Post

Some 16,000 coronavirus patients in Hong Kong have been prescribed two new oral anti-Covid drugs with favourable outcomes and few side effects being reported, according to the Hospital Authority. The authority bought the antiviral drugs molnupiravir, made by US firm MSD, and Pfizer's Paxlovid, with both having been administered to patients for two weeks. Molnupiravir was given to 12,000 patients while 4,000 took Paxlovid, according to the authority. Molnupiravir was also prescribed at designated public clinics and care homes for the elderly. The government has not disclosed how much of either drug it has bought, citing confidentiality agreements with the…